Search filters

Filters
Clear All

Phase

  • 2
  • 7
  • 2
  • 2
  • 19
  • 33
  • 13
  • 33

Found 33 HIV-infection trials

A listing of HIV-infection medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Study to Evaluate the Safety and Efficacy of GS-5423 and GS-2872 in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection

Study to Evaluate the Safety and Efficacy of GS-5423 and GS-2872 in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection

18-65 years
All genders
Phase 1
Interventional
The primary objective of this study is to evaluate the safety and tolerability of a combination of the broadly neutralizing antibodies (bNAbs) GS-5423 and GS-2872 in combination with the HIV capsid inhibitor lenacapavir (LEN).
 HIV Prevention Research Division Generic Pre-screen protocol

HIV Prevention Research Division Generic Pre-screen protocol

18-45 years
All genders
The purpose of this study is to determine if you may be eligible to participate in one of ourcurrent research studies being conducted at the University of Pennsylvania. The purposes ofthese studies are to test different methods that might protect people against viruses thatcause transmittable infections or to develop better …
 Towards Objective Metrics to Quantify the Role of HIV and Increasing Cognitive Demand on Instrumental ADLs in People Aging with HIV

Towards Objective Metrics to Quantify the Role of HIV and Increasing Cognitive Demand on Instrumental ADLs in People Aging with HIV

50-100 years
All genders
The objective of this proposal is to examine the utility of a robot-based approach to study instrumental activities of daily living (IADLs) function and cognitive-motor performance in persons aging with HIV. IADLs often require high levels of executive functioning during the performance of motor activities, but there are no good …
 Neural and Motor Functional Changes in HIV and Stroke Before and After Robot-Assisted Neurorehabilitation

Neural and Motor Functional Changes in HIV and Stroke Before and After Robot-Assisted Neurorehabilitation

18-100 years
All genders
The purpose of this research study is twofold: to study the role HIV has on the brain’s function and more particularly, the relationship between HIV and stroke; and to study how the presence of HIV effects robot-assisted rehabilitation after stroke, and its association with clinical improvement.

Neuropsychiatric sequalae of COVID-19

18-65 years
All genders
The purpose of this study is to explore possible neurological complications resulting from prior COVID-19 infection. Neurological symptoms, including ‘brain fog’, depression, and/or anxiety can be disabling. This study aims to determine the prevalence and severity of these symptoms. Unfortunately, little is known about these neuropsychiatric symptoms, particularly in patients …

The OHART Study

18-99 years
All genders
The purpose of this study is to investigate different oral and systemic problems including dental carries, periodontal disease, dry mouth, high cholesterol, diabetes, heart disease, and osteoporosis, observed in patients living with HIV on antiretroviral therapy. 
 Long Acting Therapy to Improve Treatment SUccess in Daily LifE (The LATITUDE Study)

Long Acting Therapy to Improve Treatment SUccess in Daily LifE (The LATITUDE Study)

18-70 years
All genders
Phase 3
This study is meant for patients who have difficulty taking their HIV meds as prescribed.  One goal of the study is to test the effectiveness of long-acting antiretroviral therapy (ART) -- a once-a-month injection that replaces daily ART pills. You will also receive compensation for participating in this study, with …

HVTN 313: A Phase 1 research study to test an experimental vaccine against HIV

Healthy Volunteer
All genders
The primary hypotheses are that the vaccine regimens will be safe and well tolerated and the prime-boost vaccine regimens that include Ad4-Env145NFL and Trimer 4571 as heterologous boosts will contribute to the development of B-cell and antibody (Ab) responses directed to the cross-conserved CD4 binding site (CD4bs) and gp120/gp41 fusion …

Study to Evaluate drug GS-8588 in People With HIV-1 Who are Virologically Suppressed on Antiretroviral Therapy

18-99 years
All genders
Phase 1
Interventional
The research study is being conducted to test an experimental drug, GS-8588, for the treatment and remission of human immunodeficiency virus (HIV) infection. GS-8588 is a special type of protein, called an antibody, that helps the immune system bring your immune cells closer to the cells infected with HIV. Finding …
1 - 10 of 33